Cipla Bupropion Hcl Xl Meeting Wellbutrin Bioequivalence

1 Topic Found

CIPLA got approval from the FDA to produce their generic version of Wellbutrin XL on August 30, 2016. I have made an inquiry to CIPLA as to whether their approval also means that they met the bioequivalence testing that other generic manufacturers had to comply with after Teva/Impax was pulled off the market in Sept. 2012 -- and Actavis (now owned by Watson) was removed Oct. 2013. [Second Generic Version of Popular Antidepressant to be Pulled from Market for Bioequivalency Issues]. Not sure if they have this problem corrected. Anyone know about Cipla or Watson/Actavis? ## For anyone else who may be wanting to contact Cipla USA regarding this concern, you can reach their customer service department by phone at: 844-CIPLA US (844-247-5287) or via email at: [email protected] Furthermore, it...

1 REPLY Filed under Bupropion

Can't find what you're looking for?